Sanoprost™ TR - Clinical Trials

I Product Info I Ingredients
I Recommended Use
I Clinical Trials
I Research Brief
I References


Order this item

Indication: prophylaxis and maintenance of normal prostate health, urination disturbance, urinary retention and urinary tract infections, hyperplastic process in prostate, decreased sexual activity, deterioration in sperm quality.

Actions: designed to maintain prostate health, relieves Benign Prostatic Hyperplasia (BPH) and prostatitis symptoms, provides antiseptic action, helps increase the volume and peak urine flow, decrease residual urine volume, helps increase sexual activity in men, provides durable action effect.

Ingredients (per one tablet): Saw palmetto (Serenoa repens) berries extract (8:1) (90% total sterols and free fatty acids) (equivalent to 1280 mg of crude herb) – 160 mg; Pygeum (Prunus Africana) bark extract (4:1) (25% total sterols) (equivalent to 200 mg of crude herb) - 50 mg; Stinging nettle (Urtica Dioca) root extract (25:1) (equivalent to 3000 mg of crude herb) - 120 mg.

Low USA domestic & international shipping


Sanoprost™ TR - Clinical Trials:

In the large study, European researchers gave either saw palmetto or the prescription drug Proscar to more than 1,000 men for six months. Both proved equally effective in relieving — but not eliminating — the symptoms of BPH.  (1)

The clinical effectiveness of saw palmetto has been shown in trials lasting from six months to three years. A three-year trial in Germany found that taking 160 mg of Saw Palmetto extract twice daily reduced nighttime urination in 73% of patients and improved urinary flow rates significantly. (2)

In another 12-weeks study on 1334 patients taking saw palmetto extract, 80% of the patients reported the results as good or excellent. 

One more trial with 40 men suffering from BPH, during the course of the trial they took saw palmetto extract for 60 days and demonstrated the following results: 25% reported good results, but 75% reported excellent results and decrease in BPH symptoms.
Many other studies showed the major improvement in urinary flow, and the quality of life. 

The clinical trial was conducted in Europe on 85 men between the age of 50 and 75, with mild BPH symptoms. After 2 months of treatment with pygeum extract the following results were reported: 32% of participants confirmed the decrease in nocturnal urination frequency, 31% - the improvement in the quality of life. Overall before the treatment with pygeum 2/3 of men experienced the need for 3 or more urinations during the night. After the treatment the need for bedtime urination came down to 1, and in some cases disappeared completely. These improvements continued even after the treatment with pygeum had been stopped. Some patients admitted the increase in sexual activity. (3)

Many clinical trials on animals, as well as humans, proved the effectiveness of stinging nettles. For example it was demonstrated during one of the studies that stinging nettles root extract slowed down the prostate cell growth by 30% within 5 days; another study (on mice) showed 51.4% decrease in prostatic hyperplasia.

The 134 patients (aged 53 to 84 years) with symptoms of benign prostatic hyperplasia were drawn from two medical centers in Warsaw. The patients received 300 mg of stinging nettle root extract combined with 25 mg of pygeum africanum bark extract. After 28 days treatment, urine flow, residual urine, and nocturia were significantly reduced. (4)

One more double study was conducted on 543 patients, they were treated with the combination of stinging nettle root extract and saw palmetto extract. As a result the average urine volume during urination increased, the frequency decreased, and other BPH symptoms also decreased. It demonstrated that the combination of stinging nettle root extract and saw palmetto extract is effective in reducing BPH symptoms. (5)